$KALV
KalVista Pharmaceuticals, Inc.

2020 Q3 Form 10-Q Financial Statement

#000156459020043418 Filed on September 14, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3
Revenue $0.00 $3.369M
YoY Change -100.0% -9.39%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.280M $3.250M
YoY Change 0.92% 37.13%
% of Gross Profit
Research & Development $11.17M $9.690M
YoY Change 15.27% 15.91%
% of Gross Profit
Depreciation & Amortization $128.0K $121.0K
YoY Change 5.79% 142.0%
% of Gross Profit
Operating Expenses $14.44M $12.93M
YoY Change 11.65% 20.56%
Operating Profit -$9.564M
YoY Change 36.45%
Interest Expense $700.0K $140.0K
YoY Change 400.0% -12.5%
% of Operating Profit
Other Income/Expense, Net $2.930M $2.090M
YoY Change 40.19% 5.61%
Pretax Income -$10.81M -$7.340M
YoY Change 47.28% 45.92%
Income Tax
% Of Pretax Income
Net Earnings -$10.81M -$7.338M
YoY Change 47.37% 45.88%
Net Earnings / Revenue -217.81%
Basic Earnings Per Share
Diluted Earnings Per Share -$605.6K -$419.7K
COMMON SHARES
Basic Shares Outstanding 17.82M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $64.30M $100.4M
YoY Change -35.93% 108.66%
Cash & Equivalents $18.01M $30.11M
Short-Term Investments $46.30M $70.26M
Other Short-Term Assets $3.300M $2.700M
YoY Change 22.22% 80.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $80.20M $115.7M
YoY Change -30.69% 109.64%
LONG-TERM ASSETS
Property, Plant & Equipment $3.500M $2.255M
YoY Change 55.21% -1.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.0K $173.0K
YoY Change 15.61% 0.0%
Total Long-Term Assets $3.702M $4.165M
YoY Change -11.12% 73.54%
TOTAL ASSETS
Total Short-Term Assets $80.20M $115.7M
Total Long-Term Assets $3.702M $4.165M
Total Assets $83.90M $119.9M
YoY Change -30.01% 108.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.800M $3.103M
YoY Change -41.99% 34.91%
Accrued Expenses $6.700M $4.261M
YoY Change 57.24% 37.45%
Deferred Revenue $6.023M
YoY Change -65.0%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.500M $13.97M
YoY Change -39.14% -39.01%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.000M $4.100M
YoY Change -75.61% -51.76%
Total Long-Term Liabilities $1.000M $4.050M
YoY Change -75.31% -52.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.500M $13.97M
Total Long-Term Liabilities $1.000M $4.050M
Total Liabilities $9.500M $18.02M
YoY Change -47.27% -42.62%
SHAREHOLDERS EQUITY
Retained Earnings -$99.81M
YoY Change
Common Stock $203.7M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $74.44M $101.9M
YoY Change
Total Liabilities & Shareholders Equity $83.90M $119.9M
YoY Change -30.02% 108.13%

Cashflow Statement

Concept 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$10.81M -$7.338M
YoY Change 47.37% 45.88%
Depreciation, Depletion And Amortization $128.0K $121.0K
YoY Change 5.79% 142.0%
Cash From Operating Activities -$3.588M -$11.28M
YoY Change -68.18% 81.5%
INVESTING ACTIVITIES
Capital Expenditures $22.00K $98.00K
YoY Change -77.55% -82.65%
Acquisitions
YoY Change
Other Investing Activities $5.540M -$1.430M
YoY Change -487.41%
Cash From Investing Activities $5.513M -$1.530M
YoY Change -460.33% 170.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $11.42M
YoY Change 128.44%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 46.00K 11.40M
YoY Change -99.6% 130.4%
NET CHANGE
Cash From Operating Activities -3.588M -11.28M
Cash From Investing Activities 5.513M -1.530M
Cash From Financing Activities 46.00K 11.40M
Net Change In Cash 2.225M -1.899M
YoY Change -217.17% 3.83%
FREE CASH FLOW
Cash From Operating Activities -$3.588M -$11.28M
Capital Expenditures $22.00K $98.00K
Free Cash Flow -$3.610M -$11.37M
YoY Change -68.26% 67.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
46000
CY2020Q3 us-gaap Assets
Assets
83902000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
513000
CY2019Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11422000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
18000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-7338000
CY2019Q3 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
32000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1074000
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
28000
CY2019Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-453000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1188000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5000
CY2020Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
70000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
263000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10551000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
96738000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30107000
CY2019Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
28000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
101867000
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-10814000
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-7338000
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
128000
CY2019Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
121000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1188000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1074000
CY2020Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
70000
CY2019Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
29000
CY2020Q3 kalv Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
8000
CY2019Q3 kalv Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
1000
CY2020Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
68000
CY2019Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
35000
CY2020Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
432000
CY2019Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-454000
CY2020Q3 kalv Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
-4462000
CY2019Q3 kalv Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
2060000
CY2020Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1301000
CY2019Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-561000
CY2020Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
35000
CY2019Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
392000
CY2020Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
538000
CY2019Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1117000
CY2019Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3369000
CY2020Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3588000
CY2019Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11275000
CY2020Q3 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
9807000
CY2019Q3 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
19646000
CY2020Q3 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
15342000
CY2019Q3 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
18214000
CY2020Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22000
CY2019Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
98000
CY2020Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5513000
CY2019Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1530000
CY2019Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11422000
CY2020Q3 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
46000
CY2019Q3 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
32000
CY2019Q3 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
54000
CY2020Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
46000
CY2019Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11400000
CY2020Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
254000
CY2019Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-494000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2225000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1899000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15789000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32006000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18014000
CY2019Q3 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
47000
CY2020Q3 kalv Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
64300000
CY2020Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
2602000
CY2020Q3 kalv Cash And Cash Equivalents And Marketable Securities Fair Value Disclosure
CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
48919000
CY2020Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
650000
CY2020Q2 kalv Cash And Cash Equivalents And Marketable Securities Fair Value Disclosure
CashAndCashEquivalentsAndMarketableSecuritiesFairValueDisclosure
52575000
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
45924000
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
398000
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5000
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
46317000
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
51456000
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
470000
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
51925000
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
28895000
CY2020Q3 kalv Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
7570000
CY2020Q3 kalv Available For Sale Securities Debt Maturities After Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTwoYearsFairValue
9852000
CY2020Q3 kalv Accrued Research Expense Current
AccruedResearchExpenseCurrent
2970000
CY2020Q2 kalv Accrued Research Expense Current
AccruedResearchExpenseCurrent
2333000
CY2020Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
208000
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
173000
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
47000
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
128000
CY2020Q3 kalv Contractual Obligation Remaining Commitment Including Cancellation Provisions
ContractualObligationRemainingCommitmentIncludingCancellationProvisions
3400000
CY2020Q3 kalv Amount Associated With Indemnification
AmountAssociatedWithIndemnification
0
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
489000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
386000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
242000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
145000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
145000
CY2020Q3 kalv Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
447000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1854000
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
331000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1523000

Files In Submission

Name View Source Status
0001564590-20-043418-index-headers.html Edgar Link pending
0001564590-20-043418-index.html Edgar Link pending
0001564590-20-043418.txt Edgar Link pending
0001564590-20-043418-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kalv-10q_20200731.htm Edgar Link pending
kalv-20200731.xml Edgar Link completed
kalv-20200731.xsd Edgar Link pending
kalv-20200731_cal.xml Edgar Link unprocessable
kalv-20200731_def.xml Edgar Link unprocessable
kalv-20200731_lab.xml Edgar Link unprocessable
kalv-20200731_pre.xml Edgar Link unprocessable
kalv-ex311_6.htm Edgar Link pending
kalv-ex312_8.htm Edgar Link pending
kalv-ex321_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending